Rubicon has grown revenue at a 44% CAGR since 2020, while outpacing industry growth and limiting dilution. We expect growth to accelerate in 2026 as ROMJ brings online its new Cascadia facility.

Rubicon has posted positive adjusted EBITDA since 2022, with margins expected to reach 11% in 2025 and 14% in 2026.

While cannabis equities remain at depressed valuation levels, Rubicon represents a high-quality name with a track record of growth and the backing of an elite management team and board.